TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 70 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,641 | +19.3% | 11,291 | +21.3% | 0.00% | – |
| Q2 2023 | $168,159 | +16.6% | 9,306 | -18.9% | 0.00% | – |
| Q1 2023 | $144,228 | +31.4% | 11,474 | +53.2% | 0.00% | – |
| Q4 2022 | $109,789 | -12.9% | 7,489 | +1.7% | 0.00% | – |
| Q3 2022 | $126,000 | +0.8% | 7,367 | -14.1% | 0.00% | – |
| Q2 2022 | $125,000 | +58.2% | 8,572 | +81.4% | 0.00% | – |
| Q1 2022 | $79,000 | -38.3% | 4,726 | -16.9% | 0.00% | – |
| Q4 2021 | $128,000 | +10.3% | 5,687 | +5.0% | 0.00% | – |
| Q3 2021 | $116,000 | -28.0% | 5,417 | -2.8% | 0.00% | – |
| Q2 2021 | $161,000 | +26.8% | 5,574 | +41.6% | 0.00% | – |
| Q1 2021 | $127,000 | -28.7% | 3,936 | -8.8% | 0.00% | – |
| Q4 2020 | $178,000 | – | 4,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |